-->

Sunday, March 4, 2012

ANTIGEN ANTIBODY TITRATION.immunology experiment

-->
OUCHTERLONY  DOUBLE  DIFFUSION
[ANTIGEN ANTIBODY TITRATION]
OBJECTIVE
       To learn the technique of ouchterlong double diffusion.
PRINCIPLE
      Interaction between antigen (Ag) and antibody (Ab) at the molecular level forms the basis for several techniques that are useful in modern day scientific studies and in routine clinical diagnosis. These techniques are either based on the use of labeled reagents, a tracer or immunoprecipitation. Ouchterlony double diffusion (ODD) or double immunodiffusion technique is one of the simplest techniques extensively used to check antisera for the presence of antibodies for a particular Ag and to determine its titre.
          In ODD assays, solutions of Ag and Ab are placed in adjacent wells cut in agarose gel and are allowed to diffuse radially. The Ag and Ab concentrations are relatively higher near their respective wells. As they diffuse farther from the wells, their concentration decreases. An antigen will react with its specific antibody to form an Ag-Ab complex. At one point their concentrations become equivalent and the Ag-Ab complex precipitates to form a precipitin line.


      

KIT DISCRIPTION
        In this kit, an antigen and a test antiserum are supplied. Students will perform the ODD assay to determine the titre of the antiserum, by using serially diluted antiserum against the antigen and observing the formation of precipitin line. The highest dilution at which the precipitin line is formed is considered as the titre value of the antiserum.
      
              
               KT09S : The kit is designed to carry out 15 ODD experiments.


 Duration of experiment: Experiment is carried out over a span of 2 days, approximate time taken on each day is indicated below: 
Day 1: 1 hour (Preparation of gel & loading of antigen and antiserum)
Day 2: 20 minutes (Observation and Interpretation)


MATERIALS PROVIDED
      The list below provides information about the materials supplied in the kit. The products should be stored as suggested. Use the kit within 6 months of arrival.


MATERIALS

QUANTITY

STORE

KT09S (15 EXPTS)

Agarose 2 g


2 gm


4°C

10X Assay buffer


20 ml

4°C

Antigen


0.2 ml

4°C

Test antiserum


0.5 ml

4°C

Glass plate


5 Nos

4°C

Gel punch with syringe


I Nos

4°C

Template

2 Nos


4°C





 MATERIALS REQUIRED

Glassware : Conical flask, Measuring cylinder, Test tubes.
Reagent : Distilled water.
Other Requirements: Micropipette, Tips, Moist chamber (box with wet cotton).
Note:
Ø  Read the entire procedure before starting the experiment.
Ø  Dilute the required amount of 10X assay buffer to 1X with distilled water.
Ø  Reconstitute the antigen vial with 0.2 ml of 1X assay buffer. Mix well, store at 4°C and use  within 3 months.
Ø  Reconstitute the antiserum vial with 0.5 ml of 1X assay buffer. Mix well, store at 4°C and us  within 3 months.
Ø  Wipe the glass plates with cotton, make it grease free for even spreading of agarose.
Ø  Cut the wells neatly without rugged margins.
Ø  Ensure that the moist chamber has enough wet cotton to keep the atmosphere humid.


PROTOCOL

Ø  Boil to dissolve 100 mg of agarose in 10 ml of 1X assay buffer. Cool to 55°C.
Ø  Pour 5 ml of the gel solution onto a clean glass plate placed on a horizontal surface. Allow the  gel to set, it  takes approximately 20 - 30 minutes.
Ø  Place the gel plate on the template provided. Punch wells in the gel with the help of a gel
punch corresponding to the markings on the template. Use gentle suction to avoid forming  rugged wells.
Ø  Serially dilute the test antiserum up to 1:32 dilution as follows:
o   Take 5 μl of 1X assay buffer in each of the five vials.
o   Add 5 μl of test antiserum into the first vial and mix well. The dilution of antiserum in this vial is 1:2.
o   Transfer 5 μl of 1:2 diluted antiserum from the first vial into the second vial. The dilution in this vial is 1:4.
o   Repeat the dilutions up to fifth vial
  
Ø  Add 5 μl of the antigen to the center well and 5 μl each of neat (undiluted), 1:2, 1:4,       1:8, 1:16, 1:32 dilutions of antiserum into the surrounding wells.
Ø  Place the plate in a moist chamber and incubate at room temperature, overnight.
Ø  After incubation, observe for opaque precipitin line between the antigen and antisera wells.
Ø  Note down the highest dilution at which the precipitin line is formed. This is the titre value of the antiserum.



OBSERVATION


We can see the presence of precipitin line in 1:16 dilution. So the titre value is 1:16.



 



                                                                                                                        
                           amrita.vlab.co.in/?sub=3&brch=70&sim=638&cnt=1

Thursday, March 1, 2012

new malayalam film

à´ªുà´¤ിà´¯ പടം  à´µീà´£്à´Ÿും à´’à´°ു മഹ്à´´ാ
direction : clinton .m . yuvamela
story:  ram.k pillai
screen play :nowshik api
producer: rakhi ram productions
associate : devan p hari.
editing: aji mappilai
à´µീà´£്à´Ÿും à´’à´°ു മഴ

latex agglutination


1)What is the principle behind Latex Agglutination?
When a sample containing the specific antigen (or antibody) is mixed with an antibody (or antigen) which is coated on the surface of latex particles (sensitized latex), agglutination is observed. he interaction between a particulate antigen and an antibody results in visible clumping called agglutination. Antibodies that produce such reactions are known as agglutinins. Agglutination reactions are similar in principle to precipitation reactions; they depend on the cross linking of polyvalent antigens. When the antigen is an erythrocyte it is called hemagglutination. All antibodies can theoretically agglutinate particulate antigens but IgM, due to its high valence, is particularly good agglutinin and one sometimes infers that an antibody may be of the IgM class if it is a good agglutinating antibody. Occasionally, it is observed that when the concentration of antibody is high (i.e. lower dilutions), there is no agglutination and then, as the sample is diluted, agglutination occurs. The lack of agglutination at high concentrations of antibodies which is called the prozone effect is due to antibody excess resulting in very small complexes that do not clump to form visible agglutination.


2)What is agglutination inhibition test?
    If the antibody is incubated with antigen prior to mixing with latex, agglutination is inhibited; this is because free antibodies are not available for agglutination.In agglutination inhibition , the absence of agglutination is diagnostic of antigen, provides a high sensitive assay for small quantities of antigen. for eg : Home pregnancy kits includes latex particle coated with human chorionic gonadotropin ( HCG) and antibody to HCG. HCG is a glycoprotein hormone secreted by developing placenta shortly after fertilization. The addition of urine from a pregnant women, which contains HCG , inhibits agglutination of latex particles when the anti-HCG antibody is added; thus the absence of agglutination indicates pregnancy.



3)Why is glycine-saline buffer used to reconstitute the antigen and antiserum?
It is an amino acid, one of the building blocks of proteins. Also can play a role of osmoprotectant, helping organisms to withstand osmotic stress. pKa value of glycine is 9.78, hence the effective pH range for glycine is 8.8 and 10.6.So the basisiyy will suit for reconstituting the antigen and antiserum.  

4)Why are latex beads used for coating the antigens? Can we use anything else? Why? Which would be a better option?


1.      List the conditions under which you would get a positive result in the reaction and the factors responsible for it.
2.      Suppose you do the reaction and get a negative result where you think you should observe a positive reaction. List at least 5 factors which you would consider for trouble-shooting the experiment.
3.      Suppose you do the reaction and get a positive result where you think you should observe a negative reaction because you know that the antiserum is not against that antigen. List at least 3 valid scientific reasons for such an observation.
4.      How can you test and justify if the antigen has been coated on the latex beads? (Other than testing it with the positive reaction by addition of antiserum)
5.      What is the role of blocking buffer in the experiment?
6.      Can you think of at least 5 applications for latex agglutination in diagnostics, labs, industry or research?

paramyxoviridae

Wednesday, February 29, 2012

DISCOVERY OF HUMAN BLOOD GROUP


 DISCOVERY OF HUMAN BLOOD GROUP     HISTORY
1628: Harvey discovered blood circulation
1667: French philosopher Dennis and surgeon Murrays tried the first time to transfer 150ml lamb blood to human being.
1819: Blundell completed blood transfusion from one person to another person for the first time in history.
1900: Austrian scholar Karl Landsteiner began to work on this topic since
1930: Karl Landsteiner win the Nobel Prize on human blood group

History And Experiment of Human Blood Group:
In 1900s the great Austrian biologist and physician  Karl Landsteiner   found that no aggregation phenomenon could be found when he put his own erythrocyte and blood serum together in a test tube. This is the turning point in his scientific life. Karl Landsteiner doing an experiment on the basis of no aggregation phenomenon. He mixed together erythrocyte and blood serum sourced from different individuals, that shows might be aggregation or no aggregation. This phenomenon was once observed by many people, but he was the only person who gave it an explanation. Erythrocyte has two kinds of specific structures that may exist alone or together. In 1901 he found that this effect was due to contact of blood with bloodserum. As a result he succeeded in identifying the three blood groups A, B and O, which he labeled C, of human blood. Landsteiner also found out that blood transfusion between persons with the same blood group did not lead to the destruction of blood cells, whereas this occurred between persons of different blood groups. Based on his findings. Blood serum has the antibody called agglutinin of specific structure in erythrocyte, when agglutinin meets with the specific structure in erythrocyte, aggregation will happen, which might be very dangerous when a person is on process of blood transfusion. 1907 the first successful blood transfusion was performed by Reuben Ottenberg at Mount Sinai Hospital in New York. Today it is well known that persons with blood group AB can accept donations of the other blood groups, and that persons with blood group O can donate to all other groups. Individuals with blood group AB are referred to as universal recipients and those with blood group O are known as universal donors. These donor-recipient relationships arise due to the fact that persons with AB do not form antibodies against either blood group A or B. Further, because type O blood possesses neither characteristic A nor B, the immune systems of persons with blood group AB do not refuse the donation. In today’s blood transfusions only concentrates of red blood cells without serum are transmitted, which is of great importance in surgical practice.
Then he drew the conclusion. Human blood group is genetic. His theory has placed a foundation for blood transfusion. Since blood transfusion attempts in the past always were confronted with failure, therefore common physicians restricted themselves from this field; still, a large number of scientists were carrying on various experiments relating to blood transfusion. Dramatically, the breaking-out of World War I became the event with great impetus driving the development of blood transfusion. Due to the urgent need of save the life of the wounded by war, large quantity of blood transfusion became an effective way to drive the wounded back from death. Doctor Oldenburg first applied aggregation reaction to blood matching test before blooding transfusion, and blood transfusion between human was only possible when no aggregation could be found when erythrocyte and blood serum were mixed together; this method gained great success and saved a great number of the wounded life. With continuous experiments and practices relating to blood transfusion in the following years, blood transfusion became safe; when time went to the end of 1920s, blood confusion turned a popular medical treatment in big cities in Europe and North America. 1930 Landsteiner was awarded the Nobel Prize in Physiology or Medicine in recognition of these achievements. For his pioneering work, he is recognised as the father of transfusion medicine
 


Reference
http://www.wikipipidiya.com/karl Landsteiner
http://www.schule-bw.de/unterricht/faecher/englisch/bilingual/subjects/biology/blood/bloodlab.pdf
Images: http://www.biologycorner.com/anatomy/blood/notes_bloodtype.html
2003 Blackwell Publishing Ltd,British Journal of Hematology, 2003, 121, 556–565
Submitted by
Clinton.m.u
U3bit10012
S4bsc bt

JavaScript Free Code